| 000 | 01498 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516231449.0 | ||
| 264 | 0 | _c20150727 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1941-837X | ||
| 024 | 7 |
_a10.3111/13696998.2014.959589 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCampone, Mario | |
| 245 | 0 | 0 |
_aCost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe. _h[electronic resource] |
| 260 |
_bJournal of medical economics _cDec 2014 |
||
| 300 |
_a837-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 700 | 1 | _aYang, Hongbo | |
| 700 | 1 | _aFaust, Elizabeth | |
| 700 | 1 | _aKageleiry, Andrew | |
| 700 | 1 | _aSignorovitch, James E | |
| 700 | 1 | _aZhang, Jie | |
| 700 | 1 | _aGao, Haitao | |
| 773 | 0 |
_tJournal of medical economics _gvol. 17 _gno. 12 _gp. 837-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3111/13696998.2014.959589 _zAvailable from publisher's website |
| 999 |
_c24137189 _d24137189 |
||